230 related articles for article (PubMed ID: 10482215)
1. Differential permethrin susceptibility of head lice sampled in the United States and Borneo.
Pollack RJ; Kiszewski A; Armstrong P; Hahn C; Wolfe N; Rahman HA; Laserson K; Telford SR; Spielman A
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):969-73. PubMed ID: 10482215
[TBL] [Abstract][Full Text] [Related]
2. Pyrethroid pediculicide resistance of head lice in Canada evaluated by serial invasive signal amplification reaction.
Marcoux D; Palma KG; Kaul N; Hodgdon H; Van Geest A; Previte DJ; Abou-Elghar GE; Yoon KS; Clark JM
J Cutan Med Surg; 2010; 14(3):115-8. PubMed ID: 20487671
[TBL] [Abstract][Full Text] [Related]
3. Clinical evidence of lice resistance to over-the-counter products.
Burkhart CG ; Burkhart CN
J Cutan Med Surg; 2000 Oct; 4(4):199-201. PubMed ID: 11231198
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States.
Meinking TL; Serrano L; Hard B; Entzel P; Lemard G; Rivera E; Villar ME
Arch Dermatol; 2002 Feb; 138(2):220-4. PubMed ID: 11843643
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of three pediculicides to treat head lice infestation in primary school girls: a randomised controlled assessor blind trial in rural Iran.
Kalari H; Soltani A; Azizi K; Faramarzi H; Moemenbellah-Fard MD
BMC Dermatol; 2019 Sep; 19(1):13. PubMed ID: 31510998
[TBL] [Abstract][Full Text] [Related]
6. Evidence for double resistance to permethrin and malathion in head lice.
Downs AM; Stafford KA; Harvey I; Coles GC
Br J Dermatol; 1999 Sep; 141(3):508-11. PubMed ID: 10583056
[TBL] [Abstract][Full Text] [Related]
7. Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides.
Burkhart CG
Mayo Clin Proc; 2004 May; 79(5):661-6. PubMed ID: 15132409
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 1% permethrin for the treatment of head louse infestations among Kosovar refugees.
Manjrekar RR; Partridge SK; Korman AK; Barwick RS; Juranek DD
Mil Med; 2000 Sep; 165(9):698-700. PubMed ID: 11011544
[TBL] [Abstract][Full Text] [Related]
9. Permethrin resistance in the head louse Pediculus capitis from Israel.
Mumcuoglu KY; Hemingway J; Miller J; Ioffe-Uspensky I; Klaus S; Ben-Ishai F; Galun R
Med Vet Entomol; 1995 Oct; 9(4):427-32, 447. PubMed ID: 8541597
[TBL] [Abstract][Full Text] [Related]
10. Permethrin-resistant human head lice, Pediculus capitis, and their treatment.
Yoon KS; Gao JR; Lee SH; Clark JM; Brown L; Taplin D
Arch Dermatol; 2003 Aug; 139(8):994-1000. PubMed ID: 12925385
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of chemical and botanical pediculicides in Thailand and 4% dimeticone against head louse, Pediculus humanus capitis.
Yingklang M; Gordon CN; Jaidee PH; Thongpon P; Pinlaor S
PLoS One; 2023; 18(6):e0287616. PubMed ID: 37352268
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia.
Hunter JA; Barker SC
Parasitol Res; 2003 Aug; 90(6):476-8. PubMed ID: 12827503
[TBL] [Abstract][Full Text] [Related]
13. Widespread insecticide resistance in head lice to the over-the-counter pediculocides in England, and the emergence of carbaryl resistance.
Downs AM; Stafford KA; Hunt LP; Ravenscroft JC; Coles GC
Br J Dermatol; 2002 Jan; 146(1):88-93. PubMed ID: 11841371
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of treatments for pediculosis capitis infestations: update 2000.
Meinking TL; Entzel P; Villar ME; Vicaria M; Lemard GA; Porcelain SL
Arch Dermatol; 2001 Mar; 137(3):287-92. PubMed ID: 11255326
[TBL] [Abstract][Full Text] [Related]
15. Review of common therapeutic options in the United States for the treatment of pediculosis capitis.
Jones KN; English JC
Clin Infect Dis; 2003 Jun; 36(11):1355-61. PubMed ID: 12766828
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Pediculus humanus var. capitis infestation in Cowlitz County, Washington, with ivermectin and the LiceMeister comb.
Bell TA
Pediatr Infect Dis J; 1998 Oct; 17(10):923-4. PubMed ID: 9802639
[No Abstract] [Full Text] [Related]
17. High in vitro efficacy of Nyda L, a pediculicide containing dimeticone.
Oliveira FA; Speare R; Heukelbach J
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1325-9. PubMed ID: 17958836
[TBL] [Abstract][Full Text] [Related]
18. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial.
Heukelbach J; Pilger D; Oliveira FA; Khakban A; Ariza L; Feldmeier H
BMC Infect Dis; 2008 Sep; 8():115. PubMed ID: 18783606
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of pediculicides for head lice.
Burkhart CG; Burkhart CN
Expert Opin Drug Saf; 2006 Jan; 5(1):169-79. PubMed ID: 16370965
[TBL] [Abstract][Full Text] [Related]
20. Overdiagnosis and consequent mismanagement of head louse infestations in North America.
Pollack RJ; Kiszewski AE; Spielman A
Pediatr Infect Dis J; 2000 Aug; 19(8):689-93; discussion 694. PubMed ID: 10959734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
